Dersimelagon, an effective oral treatment for patients with erythropoietic protoporphyria: Phase 2 trial

Press/Media

Period	7 Jul 2023

Media coverage

Title	Dersimelagon, an effective oral treatment for patients with erythropoietic protoporphyria: Phase 2 trial
Media name/outlet	Medical Dialogues
Country/Territory	India
Date	7/07/23
URL	https://medicaldialogues.in/dermatology/news/dersimelagon-an-effective-oral-treatment-for-patients-with-erythropoietic-protoporphyria-phase-2-trial-113896
Persons	Manisha Balwani